Russian health-care watchdog Roszdravnadzor told the daily Kommersant on August 22 that U.S pharmaceutical company MSD (Merck Corporation) will stop supplying Russia with the popular Zepatier hepatitis C medicine after its planned deliveries end in late 2024. After Russian launched its full-scale invasion of Ukraine in February 2022, MSD stopped supplying Russia with Raltegravir, a medicine to decrease the chances that HIV-infected people will develop AIDS. Another Russian periodical, Vedomosti, reported that the popular Japanese garments retailer Uniqlo had stopped its operations in Russia. To read the original stories by RFE/RL's Russian Service, click here.
U.S Pharmaceutical Company To Stop Supplying Russia With Popular Hepatitis Drug
